PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31740989-5	2020	In agreement with our previous genotyping data, the genetic polymorphism of uridine 5"-diphospho-glucuronosyltransferase (UGT)1A1*6, which affects the glucuronidation activity and circulating glucuronic acid level was identified as one of the determinants of MMI-induced hepatotoxicity.	Uridine	76-83	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	122-129	
24910925-1	2014	AIM: To evaluate the impact of genetic polymorphisms in uridine 5"-glucuronosylytansferases UGT1A1 and UGT1A3 and iodothyronine-deiodinases types 1 and 2 on levothyroxine (T4 ; 3,5,3",5"-triiodo-L-thyronine) dose requirement for suppression of thyrotropin (TSH) secretion in patients with differentiated thyroid cancer (DTC).	Uridine	56-63	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	92-98	
22943620-4	2012	In a recombinant human UGT1A1 assay, the assay buffer components uridine and its phosphorylated derivatives are isobaric with RBV and its phosphorylated metabolites, leading to significant interference when analyzed by LC-MS with the nominal mass resolution mode.	Uridine	65-72	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	23-29	
17608024-1	2007	Genetic polymorphisms of uridine 5"-diphospho-glucuronosyl-transferase (UGT)1A1, a crucial drug-metabolizing enzyme of the anticancer drug irinotecan, are essential determinants of individual variation in susceptibility to irinotecan-related toxicity.	Uridine	25-32	UDP glucuronosyltransferase family 1 member A1	Homo sapiens	72-79